首页> 外文期刊>Japanese Journal of Ophthalmology >Long-term visual outcome in primary microtropia.
【24h】

Long-term visual outcome in primary microtropia.

机译:原发性微晶状体的长期视觉结果。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To study the long-term visual outcome of primary microtropia. METHODS: A retrospective review was made on 31 patients with primary microtropia with the follow-up period of 5 years or more (5-15 years, mean=9.2 years) seen during 16 years from 1985 to 2000 at Okayama University Hospital. The patients were 16 boys and 15 girls, with the age at the initial visit ranging from 5 to 16 years (mean=9.3 years). RESULTS: All patients showed anomalous retinal correspondence, peripheral fusion, 10 prism diopters or smaller esodeviation at the initial and final visit. At the initial visit, TNO stereoacuity was absent in 24 patients, 480 seconds in 3, and 240 seconds in 4. The visual acuity was 0.8 or better in both eyes of 16 patients, but 0.7 or worse in 1 eye or both eyes of 15 patients. At the final visit, the 24 patients with the absence of stereoacuity still showed its absence, while stereoacuity remained unchanged or improved in the 7 patients with initial stereoacuity of 480 seconds or better. In the 15 patients with 0.7 or worse visual acuity, it improved to 0.8 or better in 7 patients while it remained 0.7 or worse in the other 8 patients. Poor visual acuity had no relation to the absence of TNO stereoacuity at the initial and final visits. CONCLUSION: Patients with primary microtropia could be largely classified into those with the absence of TNO stereoacuity throughout the course of treatment and those with some levels of stereoacuity that had a chance to improve during the follow-up.
机译:目的:研究原发性微晶状体的长期视觉效果。方法:回顾性分析冈山大学医院自1985年至2000年的16年中收治的31例原发性微晶状体患者,随访期5年或以上(5-15年,平均= 9.2年)。患者为16名男孩和15名女孩,初次就诊年龄为5至16岁(平均9.3岁)。结果:所有患者在初次和最终访视时均显示异常的视网膜对应,周围融合,10棱镜屈光度或较小的内镜。初诊时,24例患者无TNO立体视,3例中无480秒,4例中无240秒。16例患者的双眼视力为0.8或更好,1眼或15眼的双眼视力为0.7或更低。耐心。在最后一次访视时,24例缺乏立体视力的患者仍显示其缺乏视力,而7例初始立体视力为480秒或更佳的患者的立体视力保持不变或有所改善。在15位视力为0.7或更低的患者中,有7位患者的视力提高到0.8或更高,而其他8位患者的视力保持在0.7或更低。初次和最终访视时视力差与TNO立体视力不相关。结论:原发性微晶状体病患者可大致分为在整个治疗过程中无TNO立体视的患者和某些立体视水平在随访期间有改善机会的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号